- Home
- CRGO vs AARD Comparison
CRGO vs AARD Comparison
Compare CRGO & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRGO
- AARD
- Stock Information
- Founded
- CRGO 2012
- AARD 2017
- Country
- CRGO Spain
- AARD United States
- Employees
- CRGO N/A
- AARD 31
- Industry
- CRGO Blank Checks
- AARD Biotechnology: Pharmaceutical Preparations
- Sector
- CRGO Finance
- AARD Health Care
- Exchange
- CRGO Nasdaq
- AARD Nasdaq
- Market Cap
- CRGO 165.6M
- AARD 186.3M
- IPO Year
- CRGO N/A
- AARD 2025
- Fundamental
- Price
- CRGO $3.01
- AARD $8.59
- Analyst Decision
- CRGO
- AARD Strong Buy
- Analyst Count
- CRGO 0
- AARD 5
- Target Price
- CRGO N/A
- AARD $32.60
- AVG Volume (30 Days)
- CRGO 82.6K
- AARD 165.6K
- Earning Date
- CRGO 08-18-2025
- AARD 08-13-2025
- Dividend Yield
- CRGO N/A
- AARD N/A
- EPS Growth
- CRGO N/A
- AARD N/A
- EPS
- CRGO N/A
- AARD N/A
- Revenue
- CRGO $27,155,000.00
- AARD N/A
- Revenue This Year
- CRGO $27.56
- AARD N/A
- Revenue Next Year
- CRGO $24.45
- AARD N/A
- P/E Ratio
- CRGO N/A
- AARD N/A
- Revenue Growth
- CRGO 27.02
- AARD N/A
- 52 Week Low
- CRGO $1.27
- AARD $4.88
- 52 Week High
- CRGO $4.42
- AARD $19.58
- Technical
- Relative Strength Index (RSI)
- CRGO 42.62
- AARD N/A
- Support Level
- CRGO $3.15
- AARD N/A
- Resistance Level
- CRGO $3.24
- AARD N/A
- Average True Range (ATR)
- CRGO 0.18
- AARD 0.00
- MACD
- CRGO -0.05
- AARD 0.00
- Stochastic Oscillator
- CRGO 0.00
- AARD 0.00
About CRGO Freightos Limited Ordinary shares
Freightos Ltd operates as a vendor-neutral booking and payment platform for international freight. Its platform supports supply chain efficiency and agility by enabling real-time procurement of ocean and air shipping across more than ten thousand importers/exporters. forwarders, and dozens of airlines and ocean carriers. WebCargo by Freightos is a freight platform connecting carriers and forwarders in particular an air cargo eBooking platform. Freightos.com is a digital international freight marketplace for importers and exporters for instant pricing, booking, and shipment management. The company operates in two segments-Platform segment and Solutions segment. Geographically, the company operates in Europe, Hong Kong, United States which is majority revenue generator and others.
About AARD Aardvark Therapeutics Inc. Common Stock
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.